Wu H - Search Results

1

Genetic strategy to decrease complement activation with adenoviral therapies.

Gentile CM, Borovjagin AV, Richter JR, Jani AH, Wu H, Zinn KR, Warram JM. Gentile CM, et al. Among authors: wu h. PLoS One. 2019 Apr 26;14(4):e0215226. doi: 10.1371/journal.pone.0215226. eCollection 2019. PLoS One. 2019. PMID: 31026285 Free PMC article.

2

An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles.

Saini V, Martyshkin DV, Mirov SB, Perez A, Perkins G, Ellisman MH, Towner VD, Wu H, Pereboeva L, Borovjagin A, Curiel DT, Everts M. Saini V, et al. Among authors: wu h. Small. 2008 Feb;4(2):262-9. doi: 10.1002/smll.200700403. Small. 2008. PMID: 18200644

3

Derivation of a triple mosaic adenovirus for cancer gene therapy.

Tang Y, Wu H, Ugai H, Matthews QL, Curiel DT. Tang Y, et al. Among authors: wu h. PLoS One. 2009 Dec 31;4(12):e8526. doi: 10.1371/journal.pone.0008526. PLoS One. 2009. PMID: 20046872 Free PMC article.

4

HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.

Matthews QL, Fatima A, Tang Y, Perry BA, Tsuruta Y, Komarova S, Timares L, Zhao C, Makarova N, Borovjagin AV, Stewart PL, Wu H, Blackwell JL, Curiel DT. Matthews QL, et al. Among authors: wu h. PLoS One. 2010 Jul 27;5(7):e11815. doi: 10.1371/journal.pone.0011815. PLoS One. 2010. PMID: 20676400 Free PMC article.

5

Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.

Short JJ, Rivera AA, Wu H, Walter MR, Yamamoto M, Mathis JM, Curiel DT. Short JJ, et al. Among authors: wu h. Mol Cancer Ther. 2010 Sep;9(9):2536-44. doi: 10.1158/1535-7163.MCT-10-0332. Epub 2010 Aug 24. Mol Cancer Ther. 2010. PMID: 20736345 Free PMC article.

6

Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells.

Borovjagin AV, Dong J, Passineau MJ, Ren C, Lamani E, Mamaeva OA, Wu H, Keyser E, Murakami M, Chen S, MacDougall M. Borovjagin AV, et al. Among authors: wu h. PLoS One. 2011;6(10):e24281. doi: 10.1371/journal.pone.0024281. Epub 2011 Oct 7. PLoS One. 2011. PMID: 22003382 Free PMC article.

7

Using multivalent adenoviral vectors for HIV vaccination.

Gu L, Li ZC, Krendelchtchikov A, Krendelchtchikova V, Wu H, Matthews QL. Gu L, et al. Among authors: wu h. PLoS One. 2013;8(3):e60347. doi: 10.1371/journal.pone.0060347. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555957 Free PMC article.

8

Gene transfer to cervical cancer with fiber-modified adenoviruses.

Rein DT, Breidenbach M, Wu H, Han T, Haviv YS, Wang M, Kirby TO, Kawakami Y, Dall P, Alvarez RD, Curiel DT. Rein DT, et al. Among authors: wu h. Int J Cancer. 2004 Sep 20;111(5):698-704. doi: 10.1002/ijc.20295. Int J Cancer. 2004. PMID: 15252838 Free article.

9

Identification of sites in adenovirus hexon for foreign peptide incorporation.

Wu H, Han T, Belousova N, Krasnykh V, Kashentseva E, Dmitriev I, Kataram M, Mahasreshti PJ, Curiel DT. Wu H, et al. J Virol. 2005 Mar;79(6):3382-90. doi: 10.1128/JVI.79.6.3382-3390.2005. J Virol. 2005. PMID: 15731232 Free PMC article.

10

Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy.

Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, Chada S, Alvarez RD, Haisma HJ, Dent P, Curiel DT. Mahasreshti PJ, et al. Among authors: wu h. Gynecol Oncol. 2006 Mar;100(3):521-32. doi: 10.1016/j.ygyno.2005.08.042. Epub 2005 Oct 12. Gynecol Oncol. 2006. PMID: 16225913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43,870 results

Search Page